Page last updated: 2024-08-23

mifepristone and Argentaffinoma

mifepristone has been researched along with Argentaffinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Bruin, C; de Herder, WW; Feelders, RA; Hofland, LJ; Lamberts, SW; Nieman, LK; Sprij-Mooij, DM; van Essen, M; van Koetsveld, PM; Waaijers, AM1
Broadus, AE; Deftos, LJ; Gazdar, AF; Ikeda, K; Lu, C; Mangin, M1

Other Studies

2 other study(ies) available for mifepristone and Argentaffinoma

ArticleYear
Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:2

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Carcinoid Tumor; Cushing Syndrome; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Lung Neoplasms; Male; Middle Aged; Mifepristone; Receptors, Somatostatin

2012
Glucocorticoid regulation of parathyroid hormone-related peptide gene transcription in a human neuroendocrine cell line.
    Molecular endocrinology (Baltimore, Md.), 1989, Volume: 3, Issue:12

    Topics: Calcitonin; Carcinoid Tumor; Gene Expression Regulation; Glucocorticoids; Humans; Mifepristone; Multigene Family; Neoplasm Proteins; Neurosecretory Systems; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; RNA, Messenger; Transcription, Genetic; Triamcinolone; Tumor Cells, Cultured

1989